This was the stock's third consecutive day of gains.

As Bird Flu Outbreak Worsens, Zoetis Gets Green Light for Poultry Vaccine By India Edwards HealthDay Reporter TUESDAY, Feb.

A New Jersey pharmaceutical company has received a “a conditional license" for its bird flu vaccine for use in chickens. An ...

Rule Breaker Investing has been built on episodic series. It's not true every week, but many a week we're adding the next ...

Greenwich Academy's 2025 commencement speaker is Kristin Coveny Peck, the CEO of Zoetis, an animal health company.

Both of these metrics are at their most attractive levels in the company's history, making this a once-in-a-decade opportunity. Its discounted price combined with a long track record of steady growth, ...

Zoetis received a USDA conditional license for its H5N2 avian flu vaccine for chickens, marking a step in addressing the ...

Zoetis was granted a conditional license for its avian influenza vaccine for use in chickens. It's a step closer to fighting ...

BTIG lowered the firm’s price target on Zoetis (ZTS) to $200 from $225 and keeps a Buy rating on the shares. The company delivered an in-line ...

Zoetis has been granted a conditional license from the USDA for its avian flu vaccine. Since February 2022, more than 150 ...

Turkey’s ramped-up exports come as avian flu has killed more than 140 million egg-laying birds in the United States since 2022, and 17 million alone in November and December. Fewer birds means fewer ...

Investment analysts at William Blair reduced their Q1 2025 EPS estimates for shares of Zoetis in a note issued to investors ...